Literature DB >> 30980934

(Almost) All Nonstenotic Bicuspid Aortic Valves Should Be Preserved or Repaired.

Shunsuke Miyahara1, Ulrich Schneider1, Lucie Morgenthaler1, Hans-Joachim Schäfers2.   

Abstract

Valve preservation or repair of the regurgitant bicuspid aortic valve (BAV) minimizes valve-related complications. The purpose of the current analysis was to determine the proportion of BAVs than can be repaired. Between 2000 and 9/2018, 1168 operations for BAV without stenotic pathology were performed. Of these, 103 underwent isolated aortic valve replacement, the remaining 1055 individuals underwent valve repair. Reasons for replacement were analyzed. The proportion of repaired BAVs remained constant at 85% over the years. The most frequent reasons for replacement were cusp calcification or active endocarditis. In only 2 instances, replacement was performed as intraoperative conversion after failed repair. The vast majority of BAVs can be repaired with good durability as long as cusp substance is preserved.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BAV; Cusp; Intraoperative

Mesh:

Year:  2019        PMID: 30980934     DOI: 10.1053/j.semtcvs.2019.03.008

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  3 in total

1.  Early results of geometric ring annuloplasty for bicuspid aortic valve repair during aortic aneurysm surgery.

Authors:  Marc W Gerdisch; T Brett Reece; Dominic Emerson; Richard S Downey; Geoffrey B Blossom; Arun Singhal; Joshua N Baker; Theodor J M Fischlein; Vinay Badhwar
Journal:  JTCVS Tech       Date:  2022-06-09

2.  Twenty-five years' experience with root remodeling and bicuspid aortic valve repair.

Authors:  Lennart Froede; Karen B Abeln; Tristan Ehrlich; Susanne K Feldner; Hans-Joachim Schäfers
Journal:  Ann Cardiothorac Surg       Date:  2022-07

Review 3.  Which Aortic Valve Can Be Surgically Reconstructed?

Authors:  Karen B Abeln; Christian Giebels; Tristan Ehrlich; Jan M Federspiel; Hans-Joachim Schäfers
Journal:  Curr Cardiol Rep       Date:  2021-07-02       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.